The effect of a single dose of mifepristone (RU486) on the fine structure of the human endometrium during the early luteal phase

被引:29
作者
Dockery, P
Ismail, RMJ
Li, TC
Warren, MA
Cooke, ID
机构
[1] JESSOP HOSP WOMEN,SHEFFIELD,S YORKSHIRE,ENGLAND
[2] UNIV SHEFFIELD,DEPT BIOMED SCI,SHEFFIELD S10 2TN,S YORKSHIRE,ENGLAND
关键词
electron microscopy; endometrial glands; mifepristone; morphometry; RU486;
D O I
10.1093/humrep/12.8.1778
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study examined the fine structure of the human endometrial glandular epithelium after the administration of a single dose of RU486 (mifepristone), given in the early luteal phase, The drug was administered on days 2, 3, 5 and 6 after the luteinizing hormone peak (LH + 0), Biopsies were performed on days LH + 5, 6, 8 and 9, These were compared with control biopsies taken on corresponding days, Qualitatively, the main cytological effect of the RU486 was on the secretory apparatus and on the polarity of the cell, The formation of the nuclear channel system was also affected by the drug, A two-way analysis of variance on cell and nuclear volume data revealed no significant effect of day of biopsy, condition or interaction, Mitochondrial volume and secretory apparatus volume data revealed a significant effect of day of biopsy and interaction term; mitochondrial volume at LH + 5 was 95.9 +/- 25.3 mu m(3) (mean a SD) for control and 57.7 +/- 31.9 mu m(3) for RU486-treated epithelium. The volume of the secretory apparatus in the treated group was smaller on days LH+5 and 6 (14.6 +/- 4.2 mu m(3), 6.41 +/- mu m(3)) when compared to daymatched control biopsies (35.9 +/- 10.5 mu m(3), 41.7 +/- 26.4 mu m(3)). RU486 administration in the early luteal phase disrupted the secretory activity of the cells, These findings provide an insight into the cellular mechanisms of progesterone receptor blockade in the peri-implantation period.
引用
收藏
页码:1778 / 1784
页数:7
相关论文
共 32 条
  • [11] DOCKERY P, 1996, HUM REPROD, V11, P101
  • [12] Effect of low weekly doses of mifepristone on ovarian function and endometrial development
    GemzellDanielsson, K
    Westlund, P
    Johannisson, E
    Swahn, ML
    Bygdeman, M
    Seppala, M
    [J]. HUMAN REPRODUCTION, 1996, 11 (02) : 256 - 264
  • [13] EARLY LUTEAL-PHASE TREATMENT WITH MIFEPRISTONE (RU-486) FOR FERTILITY REGULATION
    GEMZELLDANIELSSON, K
    SWAHN, ML
    SVALANDER, P
    BYGDEMAN, M
    [J]. HUMAN REPRODUCTION, 1993, 8 (06) : 870 - 873
  • [14] Ghosh D, 1996, HUM REPROD, V11, P2026
  • [15] MIFEPRISTONE (RU-486) COMPARED WITH HIGH-DOSE ESTROGEN AND PROGESTOGEN FOR EMERGENCY POSTCOITAL CONTRACEPTION
    GLASIER, A
    THONG, KJ
    DEWAR, M
    MACKIE, M
    BAIRD, DT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (15) : 1041 - 1044
  • [16] GRAHAM RA, 1991, FERTIL STERIL, V55, P1132
  • [17] AN ENDOMETRIAL FACTOR IN UNEXPLAINED INFERTILITY
    GRAHAM, RA
    SEIF, MW
    APLIN, JD
    LI, TC
    COOKE, ID
    ROGERS, AW
    DOCKERY, P
    [J]. BRITISH MEDICAL JOURNAL, 1990, 300 (6737) : 1428 - 1431
  • [18] HERMANN WL, 1985, ANTIPROGESTIN STEROI, P199
  • [19] VASCULAR CHANGES IN THE HUMAN-ENDOMETRIUM FOLLOWING THE ADMINISTRATION OF THE PROGESTERONE ANTAGONIST RU-486
    JOHANNISSON, E
    OBERHOLZER, M
    SWAHN, ML
    BYGDEMAN, M
    [J]. CONTRACEPTION, 1989, 39 (01) : 103 - 117
  • [20] LI TC, 1988, FERTIL STERIL, V50, P52